​
Login / Signup
Idit Dotan
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 10
Top Topics
Wild Type
Cross Sectional
Drug Induced
Top Venues
Drug safety
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Bronya Calvarysky
,
Idit Dotan
,
Daniel Shepshelovich
,
Avi Leader
,
Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review.
Drug safety
47 (5) (2024)
Bronya Calvarysky
,
Idit Dotan
,
Daniel Shepshelovich
,
Avi Leader
,
Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review.
Drug safety
(2024)
Bronya Calvarysky
,
Idit Dotan
,
Daniel Shepshelovich
,
Avi Leader
,
Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review.
Drug safety
47 (5) (2024)
Bronya Calvarysky
,
Idit Dotan
,
Daniel Shepshelovich
,
Avi Leader
,
Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review.
Drug safety
47 (5) (2024)
Bronya Calvarysky
,
Idit Dotan
,
Daniel Shepshelovich
,
Avi Leader
,
Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review.
Drug safety
47 (5) (2024)
Bronya Calvarysky
,
Idit Dotan
,
Daniel Shepshelovich
,
Avi Leader
,
Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review.
Drug safety
47 (5) (2024)
Bronya Calvarysky
,
Idit Dotan
,
Daniel Shepshelovich
,
Avi Leader
,
Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review.
Drug safety
47 (5) (2024)
Bronya Calvarysky
,
Idit Dotan
,
Daniel Shepshelovich
,
Avi Leader
,
Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review.
Drug safety
47 (5) (2024)
Bronya Calvarysky
,
Idit Dotan
,
Daniel Shepshelovich
,
Avi Leader
,
Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review.
Drug safety
47 (5) (2024)
Bronya Calvarysky
,
Idit Dotan
,
Daniel Shepshelovich
,
Avi Leader
,
Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review.
Drug safety
47 (5) (2024)